Skip to content
Open access

ESRRB: from embryonic development to cancer

Sep 2026 · Clinical and Experimental Medicine (Testo stampato) · 0 citations

TL;DR

Understanding ESRRB’s dual functions in development and tumorigenesis could provide valuable insights into mechanisms of plasticity and identify novel therapeutic targets for cancers with high adaptability.

Abstract

ESRRB is an essential orphan nuclear receptor in embryonic development and in the maintenance of pluripotency. It can contribute to the self-renewal capacity of embryonic stem cells by regulating gene networks involved in cell fate decisions, influenced by core transcription factors such as NANOG, SOX2 and OCT4. Mechanistically, ESRRB links signaling inputs to chromatin accessibility and transcriptional output, enabling rapid switching between stable identity and lineage priming. Apart from its role in early development, growing evidence highlights ESRRB as a key regulator of cancer plasticity. The role of ESRRB in cancer appears to be context-dependent, as it can function either as a tumor promoter or suppressor, depending on the cancer type and cellular environment. In certain tumors, its expression has been linked to the maintenance of cancer stem cell-like properties, whereas in others, it has been associated with reduced proliferation and enhanced differentiation. Recent data further suggest that ESRRB splice isoforms (e.g., ESRRB2 and ESRRBΔ10) may encode distinct — sometimes opposing — functions that shape tumor behavior. Understanding ESRRB’s dual functions in development and tumorigenesis could provide valuable insights into mechanisms of plasticity and identify novel therapeutic targets for cancers with high adaptability.

Read PDF

Similar papers

Open access Oct 2026

Conserved phosphorylation events in ESRRB integrate diverse signaling pathways to govern the fate of embryonic stem cells

Embryonic stem cells are self-renewing, pluripotent cells, normally maintained by several pluripotency transcription factors. To respond to diverse differentiation and stress signaling pathways, the undifferentiated cell state must be destabilized before embryonic stem cells can properly interpret external signals to d...

Hao-Jie Duan, Qian Wang, Yu-Ping Suo et al. · 0 citations
Review Open access Aug 2026

Oncofetal reprogramming and cellular plasticity in colorectal cancer: from mechanisms to clinical translation

The conceptual boundaries and operational criteria for identifying OnF in CRC are discussed, its regulatory mechanisms, plasticity-associated phenotypes, and translational relevance are examined, and the importance of distinguishing direct evidence of OnF from evidence of related plasticity mechanisms is emphasized.

Hao-Yu Wang, Song-Hao Liu, Ming-Xuan Zhang et al. · 0 citations
Review Aug 2026

Homeobox genes in endocrine tumorigenesis: mechanisms, tumor microenvironment interaction, and therapeutic potential

A deeper mechanistic understanding of HOX-driven networks will aid the development of innovative biomarkers and therapies, thereby advancing precision medicine in endocrine oncology, and advancing precision medicine in endocrine oncology.

Si-Lin Kong, Ke-Xin Zhang, Cheng-Xia Kan et al. · 0 citations
Review Sep 2026

BRN2 in Lineage Plasticity: A Prostate Cancer-Focused Perspective.

This review examines how BRN2 connects developmental neurogenesis to therapy-induced tumor reprogramming and integrates insights from neurodevelopment and direct lineage reprogramming to describe how BRN2 maintains stem-like and neuroendocrine transcriptional states.

Fatemeh Seilani, Jia Peng, Meng Wu et al. · 0 citations
Open access Sep 2026

Cell-cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumors

It is demonstrated that low-dose palbociclib — at concentrations well below those required for cytostatic arrest — extends G1 without halting proliferation and that extending G1 creates a therapeutic window for epigenetic drugs.

K. Hayatigolkhatmi, R. Valzelli, E. Ceccacci et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.